The largest database of trusted experimental protocols

Polysorb

Manufactured by Medtronic
Sourced in Ireland, United States, Norway

Polysorb is a lab equipment product manufactured by Medtronic. It is a synthetic, absorbable suture material used for soft tissue approximation and/or ligation, including use in ophthalmic procedures.

Automatically generated - may contain errors

7 protocols using polysorb

1

Incisional Hernia Induction in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
We produced incisional hernias in 30 rats according to the model described previously by DuBay et al.10 (link) In an avascular prefascial plane, 6 × 3-cm rectangular full-thickness skin flaps based 2 cm lateral to the ventral midline were raised. This served to separate the skin incisions from the midline laparotomy incision. We then created a 5-cm midline laparotomy incision through the linea alba. This laparotomy incision was repaired with two interrupted, rapidly absorbed, 5-0 plain catgut sutures (Covidien, Mansfield, Mass.) placed approximately 3 mm from the cut fascial edges and equidistant from the incision ends and to each other. The skin flap was then secured in place with three deep 4-0 polyglycolic acid sutures (Polysorb; Covidien), after which the skin incision was closed in running fashion using a 4-0 poly glycolic acid suture. Neck collars were required to prevent autophagy of the incisions. The temporary laparotomy closures successfully produced fascial defects in all 30 animals. By the time the fascial closure failed, herniation of the abdominal viscera was contained by the intact skin flap closure. The incisional hernias were allowed to mature for 28 days before undergoing repair.
+ Open protocol
+ Expand
2

Measuring Seminiferous Tubule Diameters

Check if the same lab product or an alternative is used in the 5 most similar protocols
Under optical magnification, seminiferous tubules were divided into 2 groups: the tubules were measured using 5/0 surgical suture (Polysorb, Covidien) which had a diameter of 100 μm. If the diameter difference between the most dilated tubules and the finest tubules was less 50 μm (half of 5/0 surgical suture), we classified as homogeneous tubules (Fig. 2B). In contrast, if the diameter difference was 50 μm or greater, we classified as heterogeneous tubules (Fig. 2A). SRR was compared between these 2 groups.
+ Open protocol
+ Expand
3

Vascularized Hind-Limb Graft Transplantation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The recipient animal is identically sedated and prepared, and the same exposure is obtained. After dissection of the femoral vessels, the vessels are clamped and transected distally. The hind-limb graft is placed at its anatomical site using a 20-gauge intramedullary rod (BD Needles; Becton, Dickinson and Company, Franklin Lakes, NJ, USA) and absorbable 6–0 sutures (Polysorb®; Covidien, Dublin, Ireland) to reapproximate the musculature. The femoral vessels are reconnected via a non-suture cuff technique. After visual confirmation of blood flow, the skin is closed with non-absorbable nylon sutures (6–0 Ethilon®; Ethicon Inc., Somerville, NJ, USA). All animals received 0.1 mg/kg buprenorphine and 200 μl of enrofloxacin (Enroflox®; Norbrook Laboratories, Newry, UK) via subcutaneous (s.c.) injection. Animals are monitored on a heating pad until they were fully recovered before being returned to the animal housing facility. Using the previously described 4-grade rejection scale, we defined Grade 3 (skin epidermolysis) as the endpoint in this study (Fig. 1).
+ Open protocol
+ Expand
4

Experimental Laparotomy in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Experimental laparotomy was performed as previously described with minor modifications [23 (link)]. Briefly, mice were anesthetized with 2.0% isoflurane (Baxter Healthcare, Puerto Rico, USA) for 2 min, and anesthesia was maintained with 1.4% isoflurane. Mice were placed on a heating pad to maintain body temperature between 36.5–37.0 °C. After the hair was shaved and the surgical field was disinfected, an approximately 1-cm median incision was made 0.5–1 cm below the xiphoid, and approximately 5 cm of the small intestine was gently pulled out and then exposed to sterile gauze presoaked with normal saline. After being rubbed for 10 min, the intestine was returned to the abdomen. The muscle and skin were closed layer-by-layer with 5–0 absorbable sutures (Polysorb, COVIDIEN, USA). Finally, 0.1 ml 0.2% lidocaine was injected subcutaneously for postoperative analgesia. The mice were allowed to recover in an incubator at 35 °C for 30 min before being returned to their home cages.
+ Open protocol
+ Expand
5

Facial Nerve Injury Model in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gli1-CE;tdT mice aged 6 to 10 weeks were injected intraperitoneally with freshly prepared Tamoxifen (0.4 g dissolved in 20 ml of corn oil for a final concentration of 20 mg/ml) for 3 consecutive days. Approximately 8 h after the final injection, the mice were deeply anesthetized using inhaled isoflurane. Under sterile conditions using a stereomicroscope, the right facial nerve was accessed via an infra-auricular approach, with reflection of the parotid gland toward the snout. The nerve was dissected free from surrounding tissues and was sharply transected immediately inferior to the cartilage of the external auditory canal. Wounds were closed with interrupted 6–0 Polysorb (Covidien) sutures. Buprenorphine hydrochloride (0.125ml/25mg) and sterile Phosphate Buffered Saline (PBS; 0.3ml) were injected subcutaneously. Eye lubricant was placed daily to prevent corneal injury. For Hedgehog agonist treatment, FVB mice aged between 6 and 10 weeks were treated with vehicle (PBS) or intraperitoneal SAG21k (2mg/kg) (TOCRIS Biosciences; Cat. No. 5282) two days prior surgery and one day after surgery followed by one additional dose every week prior to euthanasia.
+ Open protocol
+ Expand
6

Surgical Excision of Tumor Xenografts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals with larger tumors (60–100 mm3 on day 8) were treated as previously described and anesthetized to surgically excise tumors on day 14 (day 6 post-treatment). Following a small incision to the skin the tumor was removed using suitable surgical equipment. All blood vessels were closed using a BOVIE Disposable Cautery Pen (Agntho’s AB, Lidingö, Sweden). Last, the surgical incision was closed using Polysorb™, a braided absorbable suture 5–0 from Medtronic (Oslo, Norway) and Histoacryl® biological glue from B. Braun (Melsungen, Germany). Animals that underwent surgery were given Temgesic (from the Hospital Pharmacy at Oslo University Hospital – Radiumhospitalet) subcutaneously (s.c.) twice per day at 8-h intervals (100 μl using a stock solution of 0.3 mg/ml diluted 1:10 in sterile H2O).
+ Open protocol
+ Expand
7

Applying dCELL for Neourethra Reconstruction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The dCELL is supplied in small, medium, or large sizes, as either thin (0.2–0.5 mm) or thick (>1.2 mm) variants. For all the cases in this series, we used small (3 × 3 cm) and thin (0.2–0.5 mm) dCELL (Fig. 4). Any dCELL that was found to be closer to 0.5 mm thick was easily thinned using Steven’s tenotomy scissors to make it more pliable, thereby allowing it to conform more closely to the contours of the repair. A piece of the dCELL large enough to cover the neourethra (Figs. 57) was trimmed from each sheet and sutured into place using a single continuous, peripheral suture of 6/0 or 7/0 Polysorb (Covidien, Medtronic). Once the dCELL was secured, the glans part of the repair was closed over the dCELL and the tourniquet was released to begin the process of achieving hemostasis before final skin closure. At the end of the procedure, the dCELL was palpable as a small raised area underneath the skin closure.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!